...
机译:抑制剂效力在肿瘤相关的人亚乙酸脱氢酶1突变体中广泛变化
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
Sanford Burnham Prebys Medical Discovery Institute La Jolla CA U.S.A;
Sanford Burnham Prebys Medical Discovery Institute La Jolla CA U.S.A;
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
Schr?dinger La Jolla CA U.S.A;
Department of Chemistry and Biochemistry San Diego State University San Diego CA U.S.A;
cancer metabolism; enzyme inhibitor; enzyme kinetics; enzyme mutation; IDH1; molecular dynamics;
机译:抑制剂效力在肿瘤相关的人亚乙酸脱氢酶1突变体中广泛变化
机译:2H-1 Lambda(2)-ulidin-2-One抑制剂的发现和优化突变族异柠檬酸脱氢酶1的治疗治疗癌症
机译:突变体同亚硝酸脱氢酶1抑制剂伊富辛尼与氮杂氨酸组合用于新诊断的急性髓细胞白血病(Vol 39,PG 57,2021)
机译:通过非变性质谱法定量基质和抑制剂与野生型和突变体相酯脱氢酶(IDH1)的结合
机译:使用患者衍生的胶质细胞球分子表征和解剖异柠檬酸脱氢酶1突变胶质瘤的显着特征,以达到治疗目的。
机译:在与肿瘤相关的人异柠檬酸脱氢酶1突变体中抑制剂的效价差异很大
机译:发现和优化突变异柠檬酸脱氢酶1(R132H IDH1)的变构抑制剂显示人类急性髓细胞白血病细胞的活性